封面
市場調查報告書
商品編碼
1671868

融合切片檢查市場:依切片檢查路徑、依產品、依應用、依最終使用者、按地區

Fusion Biopsy Market, By Biopsy Route, By Product, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 157 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球融合切片檢查市場規模估計為 7.911 億美元,預計 2032 年將達到 14.182 億美元,2025 年至 2032 年的複合年成長率為 8.7%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 7.911億美元
效能資料 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 8.70% 2032 年價值預測 14.182億美元
市場佔有率。
融合切片市場-IMG1

融合切片檢查結合了磁振造影(MRI)和超音波兩種醫療圖像技術,為切片檢查過程提供即時影像引導並提高準確性。這使臨床醫生能夠識別體內的可疑組織並採集組織樣本,同時最大限度地降低取樣錯誤或漏診病變的風險。全球前列腺癌、肺癌和乳癌病例的不斷增加,推動了全球對融合切片檢查等先進切片檢查技術的需求。在預計預測期內,老年人口的增加、對早期癌症診斷認知的不斷提高、醫學影像處理系統的技術進步以及新興市場的醫療支出不斷增加等因素將推動市場成長。

市場動態:

全球融合切片檢查市場受到癌症發病率上升、對微創手術的偏好增加以及對精確組織採樣技術的需求增加的推動。根據世界衛生組織預測,未來20年全球癌症發生率預計將增加70%以上。融合切片檢查有助於早期癌症檢測,同時最大限度地減少取樣誤差的可能性。這就是推動其在世界各地傳播的因素。然而,融合切片檢查設備的高安裝和維護成本抑制了市場的成長。市場進入者的機會包括擴大在新興市場的區域影響力、推出價格實惠的設備以及提供付費經營模式。越來越多整合人工智慧、機器人和 3D成像技術的先進設備的核准和推出也可能為未來幾年提供新的機會。例如,2022 年,醫療設備製造商 CMR Surgical 憑藉其用於軟組織手術的 Versius 手術機器人系統獲得了美國FDA 頒發的突破性設備稱號。

本研究的主要特點

本研究報告對全球融合切片檢查市場進行了詳細分析,並提供了預測期(2025-2032)的市場規模和年複合成長率(CAGR%),假設 2024 年為基準年。

它還揭示了不同領域的潛在商機並說明了該市場的引人注目的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球融合切片檢查市場的主要企業是根據公司亮點、產品系列、關鍵亮點、性能和策略等參數進行的分析。

主要企業包括通用電氣醫療集團、荷蘭皇家飛利浦公司、富士膠片株式會社、西門子醫療集團、日立公司、佳能醫療系統株式會社、美敦力公司、豪洛捷公司、瓦里安醫療系統、波士頓科學公司、碧迪公司、安捷倫科技公司、3M 公司、銳軟醫療系統有限公司、東軟醫療系統有限公司。

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

本研究報告針對該產業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員將透過用於分析全球融合切片檢查市場的各種策略矩陣來做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章市場動態、法規與趨勢分析

  • 市場動態

4. 2020 年至 2032 年按切片檢查途徑分類的全球融合切片檢查市場

  • 經直腸
  • 經會陰

5. 2020 年至 2032 年全球融合切片檢查市場(依產品分類)

  • 裝置
  • 耗材

6. 2020 年至 2032 年全球融合切片檢查市場(按應用)

  • 攝護腺癌
  • 其他

7. 2020 年至 2032 年全球融合切片檢查市場(按最終用戶分類)

  • 醫院
  • 診斷中心
  • 門診治療中心
  • 學術研究所
  • 其他

8. 2020 年至 2032 年全球融合切片檢查市場(按地區)

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • GE Healthcare
  • Koninklijke Philips NV
  • FUJIFILM Corporation
  • Siemens Healthineers
  • Hitachi, Ltd.
  • Canon Medical Systems Corporation
  • Medtronic
  • Hologic, Inc.
  • Varian Medical Systems
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Agilent Technologies, Inc.
  • 3M Company
  • Carestream Health
  • Neusoft Medical Systems Co., Ltd.

第 10 章分析師建議

  • 命運之輪
  • 分析師觀點
  • 一致的機會地圖

第 11 章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI7697

The Global Fusion Biopsy Market is estimated to be valued at USD 791.1 Mn in 2025and is expected to reach USD 1,418.2 Mn by 2032 exhibiting a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 791.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.70% 2032 Value Projection: USD 1,418.2 Mn
Figure. Fusion Biopsy Market Share (%), By Region, 2025
Fusion Biopsy Market - IMG1

Fusion biopsy combines two medical imaging technologies, magnetic resonance imaging (MRI), and ultrasound, to provide real-time image guidance for biopsy procedures with improved accuracy. It helps physicians locate suspicious tissue in the body and obtain tissue samples with minimal risk of sampling error or missing lesions. With rising cases of prostate, lung, and breast cancer worldwide, the demand for advanced biopsy techniques like fusion biopsy is increasing globally. Factors such as growing geriatric population, increasing awareness about early cancer diagnosis, technological advancements in medical imaging systems, and rising healthcare expenditure in developing countries are expected to drive the market growth during the forecast period.

Market Dynamics:

The global fusion biopsy market is driven by the rising prevalence of cancer, increasing preference for minimally invasive surgeries, and growing need for accurate tissue sampling techniques. According to WHO, cancer burden is expected to rise by over 70% in the next 20 years worldwide. Fusion biopsy aids in detecting cancers at an early stage with minimal chances of sampling errors. This is propelling its adoption globally. However, high installation and maintenance costs of fusion biopsy devices is restraining market growth. Opportunities for market players lie in expanding their regional presence in emerging markets, launching affordable devices and offering pay-per-use business models. Increasing approvals and launch of advanced devices integrated with artificial intelligence, robotics and 3D imaging technologies will also offer new opportunities in coming years. For example, in 2022, CMR Surgical, a medical equipment manufacturer, received breakthrough device designation from the U.S. FDA for its Versius surgical robotic system for soft tissue procedures.

Key Features of the Study:

This report provides in-depth analysis of the global fusion biopsy market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global fusion biopsy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GE Healthcare, Koninklijke Philips N.V., FUJIFILM Corporation, Siemens Healthineers, Hitachi, Ltd., Canon Medical Systems Corporation, Medtronic, Hologic, Inc., Varian Medical Systems, Boston Scientific Corporation, Becton, Dickinson and Company, Agilent Technologies, Inc., 3M Company, Carestream Health, and Neusoft Medical Systems Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global fusion biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fusion biopsy market

Market Segmentation

  • Biopsy Route Insights (Revenue, USD Mn, 2020 - 2032)
    • Transrectal
    • Transperineal
  • Product Insights (Revenue, USD Mn, 2020 - 2032)
    • Equipment
    • MRI machines
    • Ultrasound devices
    • Fusion biopsy systems
    • Others
    • Consumables
    • Biopsy needles
    • Imaging contrast agents
    • Others
  • Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Prostate Cancer
    • Others
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Hospitals
    • Diagnostic Centers
    • Ambulatory Care Centers
    • Academic & Research Laboratories
    • Others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • GE Healthcare
    • Koninklijke Philips N.V.
    • FUJIFILM Corporation
    • Siemens Healthineers
    • Hitachi, Ltd.
    • Canon Medical Systems Corporation
    • Medtronic
    • Hologic, Inc.
    • Varian Medical Systems
    • Boston Scientific Corporation
    • Becton, Dickinson and Company
    • Agilent Technologies, Inc.
    • 3M Company
    • Carestream Health
    • Neusoft Medical Systems Co., Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Fusion Biopsy Market, By Biopsy Route
    • Global Fusion Biopsy Market, By Product
    • Global Fusion Biopsy Market, By Application
    • Global Fusion Biopsy Market, By End User
    • Global Fusion Biopsy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER's Analysis
    • Merger and Acquisition Scenario
    • Industry Trends

4. Global Fusion Biopsy Market, By Biopsy Route, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Transrectal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Transperineal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Fusion Biopsy Market, By Product, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • MRI machines
    • Ultrasound devices
    • Fusion biopsy systems
    • Others
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Biopsy needles
    • Imaging contrast agents
    • Others

6. Global Fusion Biopsy Market, By Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Fusion Biopsy Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Ambulatory Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Academic & Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Fusion Biopsy Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Koninklijke Philips N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FUJIFILM Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hitachi, Ltd.
  • Canon Medical Systems Corporation
  • Medtronic
  • Hologic, Inc.
  • Varian Medical Systems
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Agilent Technologies, Inc.
  • 3M Company
  • Carestream Health
  • Neusoft Medical Systems Co., Ltd.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us